about
Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytesOverexpression of BCL2 enhances survival of human embryonic stem cells during stress and obviates the requirement for serum factors.Prospective isolation of human embryonic stem cell-derived cardiovascular progenitors that integrate into human fetal heart tissueGeneration of a monoclonal antibody library against human embryonic stem cells.Distinguishing mast cell and granulocyte differentiation at the single-cell level.Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration.Immunogenicity of human embryonic stem cells: can we achieve tolerance?Rewinding the process of mammalian extinction.Skin fibrosis. Identification and isolation of a dermal lineage with intrinsic fibrogenic potential.Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations.Manganese-guided cellular MRI of human embryonic stem cell and human bone marrow stromal cell viability.Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells.Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells.Endogenous WNT signals mediate BMP-induced and spontaneous differentiation of epiblast stem cells and human embryonic stem cellsThe safety of embryonic stem cell therapy relies on teratoma removal.Integration and differentiation of human embryonic stem cells transplanted to the chick embryo.Multimodal evaluation of in vivo magnetic resonance imaging of myocardial restoration by mouse embryonic stem cells.Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation.Immunogenicity of embryonic stem cells and their progeny.Immunological considerations for cell therapy using human embryonic stem cell derivatives
P50
Q27438164-15AC3AF9-52C8-4053-96FA-CED38D71214FQ30498247-0632DED1-9E47-4261-8C78-550024F6A1CFQ30537131-899B03A0-E47B-4DED-97AB-CEA5024F4E2AQ33331520-C87B8B27-F01F-4E20-9EC7-1FA098A2294FQ33779873-B34E712A-7E81-4BD3-8226-DB3AC2F436FDQ35608700-34240722-0496-4224-9AF6-290F436C47E0Q35953282-791E2972-2239-40A2-B5C2-1AB333909A5DQ36007952-092D7F3A-2DA6-48A7-B19F-134DCE2426F7Q37383098-5C904EC1-2C1C-436F-89D4-145DF949936DQ37863548-0CEED94E-A507-4965-967D-609F732975EAQ39837921-5A05474E-15F8-472F-A184-BBDBBF925E80Q40395995-E0DBA1AB-2E19-4C9B-A17E-4B719C1D5D8FQ41514993-7D16FAD5-131C-46E9-8936-770B1D3A479EQ41906092-EAC8BE56-5FBE-40AB-91EE-54D405EBED1CQ42609201-D8A957E8-BA63-42A9-90E5-E9EFC768628EQ44119986-DF5CD43B-9170-4E00-AEAE-E8DFFF770586Q44227682-F69835F7-37BF-4B64-ABB8-E91B8CCC50D1Q45866856-0FBCE249-3017-42D0-A8AB-97EC0DF24A3DQ45942127-2175D815-E0BB-4A42-BB67-55A93B29881FQ95000263-4EDDF284-C46F-4D29-A52E-16CCAF7F7F7A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Micha Drukker
@ast
Micha Drukker
@en
Micha Drukker
@es
Micha Drukker
@nl
type
label
Micha Drukker
@ast
Micha Drukker
@en
Micha Drukker
@es
Micha Drukker
@nl
prefLabel
Micha Drukker
@ast
Micha Drukker
@en
Micha Drukker
@es
Micha Drukker
@nl
P106
P31
P496
0000-0002-4279-1125